In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Cancer Type/Condition:  Colon cancer
Trial Type:  Prevention
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: S10251, NCT01426490

2.

Phase: Phase III, Phase II
Type: Prevention
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: SQ2011SF12RJ, SQ2011SF12-20121010, NCT02066688

3.

Phase: Phase III
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: S0820, U10CA037429, NCI-2012-02067, NCT01349881

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPP-FAP-310, NCT01483144

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 18 to 69
Sponsor: Other
Protocol IDs: D-13-01, 2013-004269-15, NCT02125409

6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01434, CDR0000671302, NCI09-13-02, NWU09-13-02, N01CN35157, P30CA060553, NU-NWU09-13-02, NCT01111292

7.

Phase: Phase II
Type: Prevention
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: 23266, KUN 2003-2911, NCT00319007

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Status: Active
Age: 40 to 120
Sponsor: NCI
Protocol IDs: NCI-2009-01192, 09-001758, MC054A, R01-CA-113681, P30CA015083, NCT00983580

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: MIRACLE, NCT01360320

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 79
Sponsor: NCI, Other
Protocol IDs: 11165, R01CA160938, NCT01661764

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MES-CT 01, NCT02077777

12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000648267, LRI-UL-CURCUMIN, EUDRACT-2007-001971-13, EU-20961, UL-CURCUMIN, NCT00973869

13.

Phase: Phase I
Type: Prevention
Status: Approved-not yet active
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: MAY2012-00-01, HHSN261201200032I, 13-829, NCT01912079

14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2014-00046, MDACC-2013-0698, MDA2013-01-02, P30CA016672, N01CN00034, NCT02052908

15.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 85
Sponsor: Other
Protocol IDs: 100106, NCT01105169

16.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 50 and over
Sponsor: Other
Protocol IDs: 2008-1122, NCT01211561

17.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention, Screening
Status: Active
Age: 50 to 75
Sponsor: NCI, Other
Protocol IDs: P01 CA090890, NCT01344330

18.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 20 to 45
Sponsor: NCI, Other
Protocol IDs: FHCRC IR 7532, NCT01619020

19.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: EPAUC/2013, NCT02069561

20.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: 13MY041, NCT02129946
New Search